Amy S. Etheridge

1.2k total citations
36 papers, 597 citations indexed

About

Amy S. Etheridge is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Amy S. Etheridge has authored 36 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Oncology and 10 papers in Pharmacology. Recurrent topics in Amy S. Etheridge's work include Pharmacogenetics and Drug Metabolism (9 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Genomics and Diagnostics (6 papers). Amy S. Etheridge is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Genomics and Diagnostics (6 papers). Amy S. Etheridge collaborates with scholars based in United States, Italy and Japan. Amy S. Etheridge's co-authors include James M. Mathews, Sherry R. Black, Purvi R. Patel, Federico Innocenti, Leo T. Burka, John L. Valentine, James Raymer, John R. Bucher, Dylan M. Glubb and Yi‐Hui Zhou and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Cancer Research.

In The Last Decade

Amy S. Etheridge

34 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy S. Etheridge United States 14 223 200 184 97 73 36 597
Jiayin Han China 15 214 1.0× 103 0.5× 188 1.0× 141 1.5× 58 0.8× 49 744
Jingzhuo Tian China 12 154 0.7× 70 0.3× 129 0.7× 115 1.2× 49 0.7× 38 438
Yushi Zhang China 12 114 0.5× 50 0.3× 101 0.5× 65 0.7× 28 0.4× 42 411
Dalia H. El‐Kashef Egypt 18 172 0.8× 38 0.2× 216 1.2× 54 0.6× 50 0.7× 46 721
Zhang‐Bin Tan China 18 108 0.5× 102 0.5× 295 1.6× 41 0.4× 38 0.5× 30 584
Yangyang Wang China 13 68 0.3× 61 0.3× 218 1.2× 123 1.3× 53 0.7× 40 592
Iman O. Sherif Egypt 16 101 0.5× 87 0.4× 187 1.0× 59 0.6× 54 0.7× 29 673
Xudong Hu China 17 121 0.5× 43 0.2× 253 1.4× 55 0.6× 46 0.6× 44 663
Arash Ghasemi Iran 14 43 0.2× 58 0.3× 115 0.6× 58 0.6× 49 0.7× 38 502

Countries citing papers authored by Amy S. Etheridge

Since Specialization
Citations

This map shows the geographic impact of Amy S. Etheridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy S. Etheridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy S. Etheridge more than expected).

Fields of papers citing papers by Amy S. Etheridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy S. Etheridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy S. Etheridge. The network helps show where Amy S. Etheridge may publish in the future.

Co-authorship network of co-authors of Amy S. Etheridge

This figure shows the co-authorship network connecting the top 25 collaborators of Amy S. Etheridge. A scholar is included among the top collaborators of Amy S. Etheridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy S. Etheridge. Amy S. Etheridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perrin, Hannah J., Swarooparani Vadlamudi, Amy S. Etheridge, et al.. (2025). Genetic effects on chromatin accessibility uncover mechanisms of liver gene regulation and quantitative traits. Genome Research. 35(7). 1485–1502.
2.
Zhang, Ting, Huixing Huang, Kelly J. Bouchonville, et al.. (2024). Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD). eLife. 13. 3 indexed citations
3.
Broadaway, K. Alaine, Sarah M. Brotman, Jonathan D. Rosen, et al.. (2024). Liver eQTL meta-analysis illuminates potential molecular mechanisms of cardiometabolic traits. The American Journal of Human Genetics. 111(9). 1899–1913. 5 indexed citations
4.
Gillis, Nancy, Amy S. Etheridge, D. Neil Hayes, et al.. (2023). Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients. The Pharmacogenomics Journal. 23(4). 73–81. 2 indexed citations
5.
Nicoletti, Paola, Andrew Dellinger, Yi‐Ju Li, et al.. (2022). Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate. Gastroenterology. 164(3). 454–466. 25 indexed citations
6.
Zhou, Yi‐Hui, Paul J. Gallins, Amy S. Etheridge, et al.. (2022). A resource for integrated genomic analysis of the human liver. Scientific Reports. 12(1). 15151–15151. 2 indexed citations
7.
Quintanilha, Júlia C.F., Susan M. Geyer, Amy S. Etheridge, et al.. (2022). KDR genetic predictor of toxicities induced by sorafenib and regorafenib. The Pharmacogenomics Journal. 22(5-6). 251–257. 5 indexed citations
8.
Quintanilha, Júlia C.F., Alessandro Racioppi, Jin Wang, et al.. (2021). PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors. The Pharmacogenomics Journal. 22(1). 82–88. 6 indexed citations
9.
Etheridge, Amy S., Deborah A. Nickerson, Nancy J. Cox, et al.. (2021). Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients. British Journal of Cancer. 126(4). 640–651. 8 indexed citations
10.
Quintanilha, Júlia C.F., Yingmiao Liu, Amy S. Etheridge, et al.. (2021). Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance). Angiogenesis. 25(1). 47–55. 7 indexed citations
11.
Innocenti, Federico, Alexander B. Sibley, Amy S. Etheridge, et al.. (2020). Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance). Clinical Cancer Research. 27(1). 267–275. 13 indexed citations
12.
Etheridge, Amy S., Eleftheria Tsakalozou, Jacqueline Ramı́rez, et al.. (2020). Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients. The AAPS Journal. 22(3). 59–59. 4 indexed citations
13.
Innocenti, Federico, Chen Jiang, Alexander B. Sibley, et al.. (2019). An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance). Pharmacogenetics and Genomics. 29(6). 123–131. 5 indexed citations
14.
Crona, Daniel J., Andrew D. Skol, Veli‐Matti Leppänen, et al.. (2018). Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib. Cancer Research. 79(1). 231–241. 25 indexed citations
15.
Luizon, Marcelo R., Walter L. Eckalbar, Yao Wang, et al.. (2016). Genomic Characterization of Metformin Hepatic Response. PLoS Genetics. 12(11). e1006449–e1006449. 40 indexed citations
16.
Glubb, Dylan M., Laia Paré, Eloísa Jantus‐Lewintre, et al.. (2015). Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I–III Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(7). 1067–1075. 15 indexed citations
17.
Mathews, James M., Qiao Zhan, Amy S. Etheridge, et al.. (2012). Metabolism and disposition of 2-methoxy-4-nitroaniline in male and female Harlan Sprague Dawley rats and B6C3F1/N mice. Xenobiotica. 42(12). 1213–1224. 2 indexed citations
18.
Mathews, James M., Sherri Brown, Purvi R. Patel, et al.. (2012). Metabolism and disposition of [14C]n-butyl-p-hydroxybenzoate in male and female Harlan Sprague Dawley rats following oral administration and dermal application. Xenobiotica. 43(2). 169–181. 10 indexed citations
19.
20.
Mathews, James M., et al.. (1997). Do Endogenous Volatile Organic Chemicals Measured in Breath Reflect and Maintain CYP2E1 Levelsin Vivo?. Toxicology and Applied Pharmacology. 146(2). 255–260. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiayin Han Breakdown of academic impact, for papers by Jingzhuo Tian Breakdown of academic impact, for papers by Yushi Zhang Breakdown of academic impact, for papers by Dalia H. El‐Kashef Breakdown of academic impact, for papers by Zhang‐Bin Tan Breakdown of academic impact, for papers by Yangyang Wang Breakdown of academic impact, for papers by Iman O. Sherif Breakdown of academic impact, for papers by Xudong Hu Breakdown of academic impact, for papers by Arash Ghasemi
Rankless by CCL
2026